PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Potential Alzheimer's disease drug slows damage and symptoms in animal model

2012-03-14
(Press-News.org) VIDEO: Kurt Brunden, Ph.D., Director of Drug Discovery at Penn's Center for Neurodegenerative Disease Research, explains a new Journal of Neuroscience study which shows that the compound epothilone D is effective...
Click here for more information.

PHILADELPHIA – A study published this week in the Journal of Neuroscience shows that the compound epothilone D (EpoD) is effective in preventing further neurological damage and improving cognitive performance in a mouse model of Alzheimer's disease (AD). The results establish how the drug might be used in early-stage AD patients.

Investigators from the Perelman School of Medicine at the University of Pennsylvania, led by first author Bin Zhang, MD, PhD, senior research investigator, and senior author Kurt R. Brunden, PhD, Director of Drug Discovery at the Center for Neurodegenerative Disease Research (CNDR), administered EpoD to aged mice that had memory deficits and inclusions within their brains that resemble the tangles formed by misfolded tau protein, a hallmark of AD. In nerve cells, tau normally stabilizes structures called microtubules, the molecular railroad tracks upon which cellular cargo is transported. Tangles may compromise microtubule stability, with resulting damage to nerve cells. A drug that could increase microtubule stability might improve nerve-cell function in AD and other diseases where tangles form in the brain.

EpoD acts by the same microtubule-stabilizing mechanism as the FDA-approved cancer drug paclitaxel (Taxol™). These drugs prevent cancer cell proliferation by over-stabilizing specialized microtubules involved in the separation of chromosomes during the process of cell division. However, the Penn researchers previously demonstrated that EpoD, unlike paclitaxel, readily enters the brain and so may be useful for treating AD and related disorders.

After three months of receiving EpoD, additional tau clumps did not form in the brains of the aged AD mice, and nerve-cell function was increased compared to the AD mice that did not receive drug. What's more, the EpoD-treated mice showed improvements in learning and memory. Importantly, the doses of EpoD that resulted in these benefits were much lower than had previously been used in Phase II clinical testing of EpoD in cancer patients. The investigators observed no side-effects – including the suppression of the immune system and peripheral nerve damage -- in the transgenic mice that received EpoD.

These results suggest that low doses of EpoD might have therapeutic benefit in AD and related neurodegenerative diseases, such as frontotemporal lobar degeneration or progressive supranuclear palsy, where tangles are the primary brain pathology.

Co-authors Virginia M.-Y. Lee, PhD, CNDR director, and John Trojanowski, MD, PhD, director of the Institute on Aging at Penn and CNDR co-director, introduced the concept of using microtubule-stabilizing drugs over 15 years ago to counteract tangles of tau and compensate for the loss of normal tau function.

The Penn CNDR researchers, in collaboration with co-authors Amos B. Smith, III, PhD, the Rhodes Thompson Professor of Chemistry, and Carlo Ballatore, PhD, from the Penn Department of Chemistry, previously identified EpoD as a lead microtubule-stabilizing agent for evaluation in AD mouse models after characterizing several members of the epothilone family of compounds. Unlike many microtubule-stabilizing compounds, EpoD readily enters the brain, where it appears to persist for a much longer time than in the blood. This feature may explain why low doses were both effective and safe in the mouse model of AD.

The work significantly extends an earlier study published in the Journal of Neuroscience in October 2010.

INFORMATION:

The research was funded by the National Institute on Aging and the Marian S. Ware Alzheimer Program.

END



ELSE PRESS RELEASES FROM THIS DATE:

Study examines outcomes among patients treated in universal health care system

2012-03-14
CHICAGO – Among hospitals in Ontario, Canada, those with higher levels of spending, which included higher intensity nursing and greater use of specialists and procedures, had an associated lower rate of deaths, hospital readmissions, and better quality of care for severely ill hospitalized patients, according to a study in the March 14 issue of JAMA. Studies have investigated whether higher health care spending produces better patient outcomes and higher quality of care, with conflicting evidence in the United States and other countries. "The extent to which better spending ...

Study finds association between genetic mutation and age at diagnosis for common childhood cancer

2012-03-14
CHICAGO – Certain mutations of the gene ATRX were associated with age at diagnosis in children and young adults with advanced-stage neuroblastoma, a cancer that grows in parts of the nervous system, according to a study in the March 14 issue of JAMA. Neuroblastoma is the most common extracranial (outside the cranium) solid tumor of childhood and accounts for 15 percent of all cancer-related deaths in children. "Half of the patients (50 percent) with neuroblastoma present with metastatic disease; with current treatment approaches, the age at diagnosis has proven to be ...

Endoscopic procedure may result in better outcomes for patients with infected severe pancreatitis

2012-03-14
CHICAGO – In a small, preliminary trial, patients with infected necrotizing pancreatitis (severe form of the disease involving devitalized pancreatic tissue) who received a less-invasive procedure, endoscopic transgastric necrosectomy (removal of the pancreatic tissue), had an associated lower risk of major complications and death compared to patients who had surgical necrosectomy, according to a study in the March 14 issue of JAMA. "Acute pancreatitis is a common and potentially lethal disorder. In the United States alone, more than 50,000 patients are admitted with ...

Treating intestinal E. coli infection with antibiotic may reduce duration of bacterial carriage

2012-03-14
CHICAGO – In the E coli outbreak in Germany in May 2011, treatment with azithromycin was associated with a lower frequency of long-term carriage of the bacteria and shorter duration of shedding of the bacteria in stool specimens, according to a study in the March 14 issue of JAMA. "Since May 2011, a large outbreak of Shiga toxin-producing Escherichia coli (STEC) has caused 3,816 documented infections in Germany, including 845 confirmed cases of hemolytic uremic syndrome [HUS; a condition characterized by the breakup of red blood cells and kidney failure]," the authors ...

Cancer drug improves memory in mouse model of Alzheimer's disease

Cancer drug improves memory in mouse model of Alzheimers disease
2012-03-14
Washington, DC — A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a study in the March 14 issue of The Journal of Neuroscience. The findings suggest the drug epothilone D (EpoD) may one day prove useful for treating people with early-stage Alzheimer's disease. Nerve cells in people with Alzheimer's disease contain tangles — distorted clumps made up of the protein tau. Under normal circumstances, tau helps stabilize structures ...

Sleep apnea treatment may protect against heart failure

2012-03-14
A nightly breathing treatment may do more than help people with obstructive sleep apnea get a good night's rest — it may also help prevent heart failure. In a study published in Circulation: Heart Failure, a journal of the American Heart Association, researchers in the U.K. discovered that moderate to severe obstructive sleep apnea (OSA) can cause changes in the heart's shape and function, similar to the effects of hypertension. These changes include increased mass, thickening of the heart wall and reduced pumping ability. But, six months after continuous positive airway ...

Text messages help HIV patients stick to antiretroviral drug therapy

2012-03-14
Mobile phones could play a valuable role in helping HIV patients to take their medication every day, according to a new Cochrane Systematic Review. The researchers found that patients were less likely to miss doses if they were sent weekly mobile phone text message reminders. Text messaging is increasingly being used as a means of support in health care, including to help promote attendance at clinics and hospitals, and to increase contact between patients and care workers. There is also some evidence that text messaging helps tuberculosis patients to take their daily ...

Specialist cancer care may improve patient outcomes

2012-03-14
Survival rates for cancer patients may be improved by treatment in specialised cancer centres, according to Cochrane researchers. In a review of recent studies, they found that women diagnosed with gynaecological cancer lived longer when treated in specialist compared to non-specialist units. In the past, cancer patients were often treated by non-specialist surgeons and hospitals. This is changing and in developed countries, most cancer care is now organised into networks of specialised centres, with on-site experts and specialised nursing staff. This centralised approach, ...

Pain relief: Poor evidence for non-drug approaches in labor

2012-03-14
There is better evidence for the effectiveness of drug-based approaches for relieving labour pains than non-drug approaches. These are the findings of an all-encompassing publishing in The Cochrane Library, which draws together results from a number of previous reviews on the subject. Many different approaches are used to relieve pain in labour, but not all are supported by strong evidence. The researchers brought together the results of 15 previous Cochrane reviews and three non-Cochrane reviews, including data from 310 trials in total. To try to distinguish between ...

Hospital survival differs among Hispanic and non-Hispanic heart failure patients

2012-03-14
The odds of surviving their hospital stay for heart failure differ between Hispanic and non-Hispanic white patients according to their level of heart function, even when they received equal care in hospitals participating in the American Heart Association's Get With The Guidelines®–Heart Failure quality improvement program, researchers said. The study, published in the American Heart Association journal, Circulation: Heart Failure, is the first in which researchers compare the care and outcomes of Hispanic to non-Hispanic heart failure patients admitted to U.S. hospitals ...

LAST 30 PRESS RELEASES:

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

Researchers discover new way cells protect themselves from damage

Rivers choose their path based on erosion — a discovery that could transform flood planning and restoration

New discovery reveals dopamine operates with surgical precision, not as a broad signal

New AI tool gives a helping hand to x ray diagnosis

New Leicester study reveals hidden heart risks in women with Type 2 Diabetes

Over 400 different types of nerve cell have been grown – far more than ever before

Newly discovered molecule may explain reduced muscle mass in type 2 diabetes

Rheumatoid arthritis and muscle wasting: New review points to overlooked complications

Overcoming intrinsic dispersion locking by misaligned bilayer metagratings

Vaccines work: Cohort data from Denmark show real-world evidence of stable protection against HPV-related cervical cancer

Underwater shaped charge explosions: a comprehensive experimental study on coupling dynamics

Wristband sensor provides all-in-one monitoring for diabetes and cardiovascular care

Unveiling the spatiotemporal landscape of Ganoderma lingzhi: insights into ganoderic acid distribution and biosynthesis

Quality and antibiotic resistance risks in livestock probiotics in China

Genomic study reveals deep roots of human survival and adaptation in Himalayas

Differential obesity trends in Asian and Native Hawaiian or other Pacific Islander US adults

Cumulative anticholinergic exposure and change in gait speed and grip strength in older adults

Study suggests lemurs age differently than humans

Hypothermia alters glucose metabolism and may reveal mechanisms of metabolic disease

[Press-News.org] Potential Alzheimer's disease drug slows damage and symptoms in animal model